PvGTSeq and PvCRiSP: Two amplicon-based targeted sequencing panels for Plasmodium vivax

dc.contributor.authorManrique-Valverde P.C.
dc.contributor.authorHasund C.M.
dc.contributor.authorKelley K.A.
dc.contributor.authorAmaya-Romero J.E.
dc.contributor.authorArévalo-Herrera M.
dc.contributor.authorBrosula R.
dc.contributor.authorCalzada J.E.
dc.contributor.authorChenet S.M.
dc.contributor.authorCorredor V.
dc.contributor.authorEarly A.M.
dc.contributor.authorFontecha G.
dc.contributor.authorForero-Peña D.A.
dc.contributor.authorHerrera S.
dc.contributor.authorLana J.T.
dc.contributor.authorLaws M.
dc.contributor.authorNiles-Robin R.
dc.contributor.authorObaldia N.
dc.contributor.authorSantamaria A.M.
dc.contributor.authorSchwabl P.
dc.contributor.authorAuburn S.
dc.contributor.authorNeafsey D.E.
dc.contributor.correspondenceManrique-Valverde P.C.
dc.contributor.otherMahidol University
dc.date.accessioned2026-05-31T18:34:46Z
dc.date.available2026-05-31T18:34:46Z
dc.date.issued2026-05-01
dc.description.abstractPlasmodium vivax is the main cause of malaria outside of sub-Saharan Africa, and in many settings it presents significant challenges to malaria elimination efforts. Despite some control successes in the Americas, regional annual case counts of malaria have increased by over 25% between 2014 and 2023, largely driven by P. vivax. Genomic surveillance can play a key role in understanding the extent to which disease persistence represents indigenous transmission as opposed to introduction of new strains through migration, and whether specific variants evade control measures. Efforts to make P. vivax genomic surveillance more cost-effective have led to the development of targeted sequencing-based methods, which strike a varying balance between assay sensitivity and breadth/informativeness. We introduce two new highly sensitive multiplexed amplicon sequencing panels for P. vivax: PvGTSeq and PvCRiSP. PvGTSeq requires selective whole-genome amplification (sWGA) and contains 249 amplicons-36 for antimalarial resistance and 213 for population structure-optimized for Latin America but applicable to all continents. PvCRiSP features four highly polymorphic amplicons that operate without sWGA and is designed to estimate complexity of infection (COI), identify instances of clonal transmission, and characterize recurrent episodes. Both panels use a single multiplex PCR with non-proprietary reagents, achieve ≥75% amplicon recovery at parasitemias as low as five parasites/μL, and PvCRiSP remains effective with low quality DNA. PvGTSeq showed high sequencing accuracy (error rate 3.85e-4% - 2.87e-3%), and both panels efficiently detected alleles from minority clones in simulated polyclonal infections. We validated both panels with samples from Colombia, Guyana, Honduras, Panama, and Venezuela, and performed in-silico assessments using data from 16 countries worldwide, confirming that these two panels have high power to discriminate samples and assign global geographic origin to imported cases. These panels will therefore be useful tools for P. vivax molecular surveillance in diverse geographic settings.
dc.identifier.citationPlos Neglected Tropical Diseases Vol.20 No.5 (2026) , e0013663
dc.identifier.doi10.1371/journal.pntd.0013663
dc.identifier.eissn19352735
dc.identifier.pmid42133746
dc.identifier.scopus2-s2.0-105039766578
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/117022
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.titlePvGTSeq and PvCRiSP: Two amplicon-based targeted sequencing panels for Plasmodium vivax
dc.typeArticle
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105039766578&origin=inward
oaire.citation.issue5
oaire.citation.titlePlos Neglected Tropical Diseases
oaire.citation.volume20
oairecerif.author.affiliationHarvard T.H. Chan School of Public Health
oairecerif.author.affiliationBroad Institute
oairecerif.author.affiliationNuffield Department of Medicine
oairecerif.author.affiliationFriedrich-Loeffler-Institute
oairecerif.author.affiliationMenzies School of Health Research
oairecerif.author.affiliationMahidol Oxford Tropical Medicine Research Unit
oairecerif.author.affiliationUniversidad de Panamá
oairecerif.author.affiliationUniversidad Nacional Autónoma de Honduras
oairecerif.author.affiliationUniversidad Nacional de Colombia, Facultad de Medicina
oairecerif.author.affiliationUniversidad Nacional Toribio Rodríguez de Mendoza de Amazonas
oairecerif.author.affiliationClinton Health Access Initiative, Inc.
oairecerif.author.affiliationMinistry of Health
oairecerif.author.affiliationMalaria Vaccine and Drug Development Center
oairecerif.author.affiliationCaucaseco Scientific Research Center
oairecerif.author.affiliationBiomedical Research and Therapeutic Vaccines Institute
oairecerif.author.affiliationInstituto Conmemorativo Gorgas de Estudios de la Salud (ICGES)

Files

Collections